Lv41
594 积分 2024-03-18 加入
Landscape of cancer cell therapies: trends and real-world data
5天前
已完结
Clinical development success rates for durable cell and gene therapies
5天前
已完结
The changing landscape of cancer cell therapies: clinical trials and real-world data
5天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
6天前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
8天前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
8天前
已完结
SMAD7 expression in CAR-T cells improves persistence and safety for solid tumors
12天前
已完结
CD70-targeted cancer theranostics: Progress and challenges
15天前
已完结
Cancer immunotherapy by γδ T cells
16天前
已完结
The emerging roles of γδ T cells in cancer immunotherapy
16天前
已完结
皖公网安备34019202002308
